home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Courses and Workshops  
 

Softgel Capsules: Formulation Design and Troubleshooting

 
  March 17, 2015  
     
 
CfPA-The Center for Professional Advancement, Burlingame, CA
August 14, 2015


Who Should Attend?
This broadly based course is intended for operators, troubleshooters and all scientists and technologists concerned with the development and processing of softgels capsules products and with related regulatory affairs.

The material will be presented in such a way as to be of value to a varying level of expertise. This course will especially benefit those in:
  • Formulating 
  • Manufacturing/Production
  • Engineering Support 
  • R&D
  • Quality Assurance 
  • Marketing
  • Validation 
  • Purchasing
  • Regulatory Affairs

Course Description
The main aim of this course is to review the science relating to softgel encapsulated pharmaceutical and nutritional products. The course begins with a consideration of the basic aspects of softgel manufacturing process, progresses through raw material/ingredients and their properties to the formulation of these ingredients for softgel both the fill and the shell materials to meet the needs of the manufacturing process. Experimental designs and QbD is considered in determining robustness of the prodcuct/process. The program concludes with key aspects of the evaluation of finished products and the investigation and troubleshooting to solving problems.

Formal sessions of the course are supplemented with informal discussion periods between lecturers and course participants and problem-solving sessions are held on both an open and private basis.
 
 
Organized by: CfPA-The Center for Professional Advancement
Invited Speakers:
Dr. Cecil W. Propst; Research Fellowt, SPI Pharma, Grand Haven

Dr. Cecil W. Propst is a Research Fellow for SPI Pharma, a processor of a variety of specialty ingredients for the food, drug, cosmetic and related industries. He was Director of R&D (Grand Haven site) at SPI Pharma until semi retirement in 2015. He served as Director of Quality Assurance and Technical Services at Fleming and Company, and before that, President of Manufacturing Chemists. His duties included system design, product and process development and regulatory affairs. Previously, he served as cGMP Facilities Director for the University of Maryland at Baltimore, in connection with the University’s SPAC contract with the FDA.

Dr. Propst also served as Director of Technical Development for Stellar Manufacturing; Director of Quality Compliance for SmithKline Beecham; Director, Quality Assurance for Norcliff Thayer (a Revlon Company); and Group Leader/Product Development and Manager/Quality Control for Lewis Howe Company. He also serves as a consultant in the area of product development and process investigations for the chemical, diagnostic, food, engineering and beverage industries.

 


 
Deadline for Abstracts: n/a
 
Registration: Please click here for registration information.
E-mail: sberg@cfpa.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.